Your browser doesn't support javascript.
loading
Combinatorial CRISPR screen identifies fitness effects of gene paralogues.
Thompson, Nicola A; Ranzani, Marco; van der Weyden, Louise; Iyer, Vivek; Offord, Victoria; Droop, Alastair; Behan, Fiona; Gonçalves, Emanuel; Speak, Anneliese; Iorio, Francesco; Hewinson, James; Harle, Victoria; Robertson, Holly; Anderson, Elizabeth; Fu, Beiyuan; Yang, Fengtang; Zagnoli-Vieira, Guido; Chapman, Phil; Del Castillo Velasco-Herrera, Martin; Garnett, Mathew J; Jackson, Stephen P; Adams, David J.
Afiliação
  • Thompson NA; Wellcome Sanger Institute, Wellcome Trust Genome Campus, Cambridge, UK.
  • Ranzani M; Wellcome Sanger Institute, Wellcome Trust Genome Campus, Cambridge, UK.
  • van der Weyden L; Wellcome Sanger Institute, Wellcome Trust Genome Campus, Cambridge, UK.
  • Iyer V; Wellcome Sanger Institute, Wellcome Trust Genome Campus, Cambridge, UK.
  • Offord V; Wellcome Sanger Institute, Wellcome Trust Genome Campus, Cambridge, UK.
  • Droop A; Wellcome Sanger Institute, Wellcome Trust Genome Campus, Cambridge, UK.
  • Behan F; Wellcome Sanger Institute, Wellcome Trust Genome Campus, Cambridge, UK.
  • Gonçalves E; Wellcome Sanger Institute, Wellcome Trust Genome Campus, Cambridge, UK.
  • Speak A; Wellcome Sanger Institute, Wellcome Trust Genome Campus, Cambridge, UK.
  • Iorio F; Wellcome Sanger Institute, Wellcome Trust Genome Campus, Cambridge, UK.
  • Hewinson J; Human Technopole, Milano, Italy.
  • Harle V; Wellcome Sanger Institute, Wellcome Trust Genome Campus, Cambridge, UK.
  • Robertson H; Wellcome Sanger Institute, Wellcome Trust Genome Campus, Cambridge, UK.
  • Anderson E; Wellcome Sanger Institute, Wellcome Trust Genome Campus, Cambridge, UK.
  • Fu B; Wellcome Sanger Institute, Wellcome Trust Genome Campus, Cambridge, UK.
  • Yang F; Wellcome Sanger Institute, Wellcome Trust Genome Campus, Cambridge, UK.
  • Zagnoli-Vieira G; Wellcome Sanger Institute, Wellcome Trust Genome Campus, Cambridge, UK.
  • Chapman P; Wellcome Trust/Cancer Research UK Gurdon Institute, Cambridge, UK.
  • Del Castillo Velasco-Herrera M; Cancer Research UK, Manchester Institute, Manchester, UK.
  • Garnett MJ; Wellcome Sanger Institute, Wellcome Trust Genome Campus, Cambridge, UK.
  • Jackson SP; Wellcome Sanger Institute, Wellcome Trust Genome Campus, Cambridge, UK.
  • Adams DJ; Wellcome Trust/Cancer Research UK Gurdon Institute, Cambridge, UK.
Nat Commun ; 12(1): 1302, 2021 02 26.
Article em En | MEDLINE | ID: mdl-33637726
ABSTRACT
Genetic redundancy has evolved as a way for human cells to survive the loss of genes that are single copy and essential in other organisms, but also allows tumours to survive despite having highly rearranged genomes. In this study we CRISPR screen 1191 gene pairs, including paralogues and known and predicted synthetic lethal interactions to identify 105 gene combinations whose co-disruption results in a loss of cellular fitness. 27 pairs influence fitness across multiple cell lines including the paralogues FAM50A/FAM50B, two genes of unknown function. Silencing of FAM50B occurs across a range of tumour types and in this context disruption of FAM50A reduces cellular fitness whilst promoting micronucleus formation and extensive perturbation of transcriptional programmes. Our studies reveal the fitness effects of FAM50A/FAM50B in cancer cells.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas / Genoma / Repetições Palindrômicas Curtas Agrupadas e Regularmente Espaçadas / Sistemas CRISPR-Cas Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas / Genoma / Repetições Palindrômicas Curtas Agrupadas e Regularmente Espaçadas / Sistemas CRISPR-Cas Idioma: En Ano de publicação: 2021 Tipo de documento: Article